首页> 美国卫生研究院文献>Gut Microbes >Biofilm formation by Clostridium difficile
【2h】

Biofilm formation by Clostridium difficile

机译:艰难梭菌生物膜的形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clostridium difficile infection (CDI) is a major healthcare-associated disease worldwide. Recurring infections and increasing antibiotic resistance have complicated treatment of CDI. While C. difficile spores are important for transmission and persistence of CDI, other factors such as gut colonization and formation of bacterial communities in the gut may also contribute to pathogenesis and persistence, but have not been well investigated. Recently, we reported that important clinical C. difficile strains are able to form composite biofilms in vitro. C. difficile biofilm formation is a complex process, modulated by several different factors, including cell surface components and regulators. We also reported that bacteria within biofilms are more resistant to high concentrations of vancomycin, the antibiotic of choice for treatment of CDI. Here we summarize our recent findings and discuss the implications of biofilm formation by this anaerobic gut pathogen in disease pathogenesis and treatment.
机译:艰难梭菌感染(CDI)是全球范围内与医疗保健相关的主要疾病。反复感染和增加的抗生素耐药性使CDI的治疗变得复杂。尽管艰难梭菌孢子对于CDI的传播和持久性很重要,但其他因素(如肠道定植和肠道细菌群落的形成)也可能有助于发病和持久性,但尚未得到充分研究。最近,我们报道了重要的临床艰难梭菌菌株能够在体外形成复合生物膜。艰难梭菌生物膜的形成是一个复杂的过程,受多种不同因素的调节,包括细胞表面成分和调节剂。我们还报告说,生物膜中的细菌对高浓度的万古霉素具有更高的抵抗力,万古霉素是治疗CDI的首选抗生素。在这里,我们总结我们最近的发现,并讨论这种厌氧肠道病原体形成生物膜在疾病发病机理和治疗中的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号